BBOT

BridgeBio Oncology
BBOT

Overview Fund Trends Analyst Outlook Journalist POV

31 hedge funds and large institutions have $171M invested in BridgeBio Oncology in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

2.44% less ownership

Funds ownership: 89.02% → 86.59% (-2.4%)

Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.25M
2
+$140K
3
+$135K
4
ACP
Acuta Capital Partners
California
+$32.5K
5
Citadel Advisors
Citadel Advisors
Florida
+$1.48K

Top Sellers

1
-$949K
2
-$534K
3
-$57.1K
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$32.2K
5
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$24.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$30.4M
2
$15.7M
3
$14.6M
4
$13.9M
5
$11.8M
6
$11.8M
7
$7.37M
8
$6.27M
9
$5.36M
10
$5.22M
11
$5.22M
12
$5.22M
13
$4.96M
14
$4.22M
15
$4.16M
16
$3.13M
17
$3.13M
18
$2.61M
19
$2.61M
20
$2.09M
21
$1.98M
22
$1.93M
23
$1.89M
24
$1.51M
25
$1.25M
1
2